| Bioactivity | Zanamivir is an influenza viral neuraminidase inhibitor with IC50 values of 0.95 nM and 2.7 nM for influenza A and B, respectively. | ||||||||||||
| Invitro | Zanamivir interacts with a group of amino acids in the active site of neuraminidase, which are conserved in all influenza A and B strains. Zanamivir blocks the action of neuraminidase, which prevents the cleavage of sialic acid on the cell receptors, thus preventing release and spread of the newly formed virions[2]. | ||||||||||||
| Name | Zanamivir | ||||||||||||
| CAS | 139110-80-8 | ||||||||||||
| Formula | C12H20N4O7 | ||||||||||||
| Molar Mass | 332.31 | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
Zanamivir
CAS: 139110-80-8 F: C12H20N4O7 W: 332.31
Zanamivir is an influenza viral neuraminidase inhibitor with IC50 values of 0.95 nM and 2.7 nM for influenza A and B, re
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.